AE Cardiff congratulates and thanks Professor Sierd Cloetingh who will complete his term as President of Academia Europaea on 31st December, having served the Academy for 7 years.
To mark the end of his tremendous presidency, Professor Cloetingh delivered his Valedictory Presidential Lecture at the Hungarian Academy of Science in Budapest in a session chaired by the Hungarian Academy’s President, Professor Tamas Freund MAE. Members of the Academia Europaea Board of Trustees and distinguished guests were in attendance. The lecture was also followed online by many members of Academia Europaea.
AE Cardiff’s Hub Manager, Louise Edwards, has received the President’s Merit Award in recognition of significant personal service to the Academia Europaea.
Louise Edwards was awarded the prize by Professor Sierd Cloetingh, President of Academia Europaea, in December 2021. The President’s Merit Award, a new award for the Academia Europaea, is a personal gift from the President. It recognises the service and contribution that an individual has made to support AE. Professor Cloetingh said,
“This is awarded as a mark of recognition for Louise’s wonderful and selfless service to the Academia over many years, and for making the difference to our role in the Scientific Advice Mechanism for the European Commission.”
Over 300 members of Academia Europaea and the Young Academy of Europe attended the Annual Conference, hosted by the Academia Europaea Barcelona Knowledge Hub.
This year’s plenary conference took place on 20th – 21st October and delegates were able to attend either online or in person at the Barcelona Biomedical Research Park. You’ll find key highlights from the event below.
The Princess of Asturias Foundation has recognised Professor Kariko for her contribution to the development of COVID-19 vaccines.
Katalin Kariko received the award in Oviedo, Spain, on Friday 22nd October, with the Spanish royal family in attendance. She was one of seven Laureates in the ‘Technical and Scientific Research’ category for 2021 recognised for contributing to the development of some of the COVID-19 vaccines approved to date.
Hungarian biochemist Professor Katalin Kariko is Senior Vice President, BioNTech RNA Pharmaceuticals and Adjunct Associate Professor at the University of Pennsylvania. Her fields of scholarship include the therapeutic use of mRNA, mRNA-based antibody therapeutics, mRNA-based protein replacement therapy and mRNA vaccines. Professor Kariko’s research, together with immunologist Drew Weissman, led to the development of the Moderna and Pfizer-BioNTech vaccines. Together, they have received several awards for their revolutionary research, including the Lasker-DeBakey Clinical Medical Research Award. Professor Kariko was elected to the Academia Europaea in 2020.
Nature Medicine, a top research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians, has published an article by Professor Péter Hegyi MAE and colleagues.
The article titled ‘Accelerating the translational medicine cycle: the Academia Europaea pilot’ explores the need for improvement in implementing scientific results in healthcare. In the article, Hegyi, P., Erőss, B., Izbéki, F. et al. introduce a new Translational Medicine (TM) model that facilitates and accelerates the application of scientific knowledge for community benefit.